New indication for Eylea in EU: treatment of visual impairment due to macular edema secondary to central retinal vein occlusion
Bayer HealthCare has announced that Eylea ( Aflibercept solution for injection ) has been approved by the European Commission ( EC ) for the treatment of visual impairment due to macular edema seconda ...
read article